@inproceedings{inproceedings, title  = {{Fracture-related hospitalisations in de novo advanced or metastatic hormonesensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone plus /- enzalutamide and M1|RT phase 3 trials using health systems data}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Jones C and Dutey-Magni P and Murphy L and Murray M and Brown J and Mccloskey E and Parmar MKB and Parker C and Attard G and James ND and Sydes MR et al}},

 volume = {{85}},

 journal = {{EUROPEAN UROLOGY}},

 pages = {{S1583-S1583}},

 note = {{Accessed on 2024/12/27}}}